deltatrials
Recruiting NA INTERVENTIONAL 1-arm NCT04662905

Novel Treatment Delivery of ECAP-controlled Closed-loop SCS for Chronic Pain (Freshwater)

A Prospective, Multicentre, Single-arm Feasibility Study Examining Novel Treatment Delivery of the Evoke Spinal Cord Stimulator (SCS) System to Treat Patients With Chronic Pain of the Trunk and/or Limbs

Sponsor: Saluda Medical Pty Ltd

Conditions Chronic Pain
Interventions Evoke Spinal Cord Stimulation (SCS) System
Updated 15 times since 2021 Last updated: May 12, 2025 Started: Dec 15, 2020 Primary completion: Jan 1, 2027 Completion: Jan 1, 2027
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT04662905, this NA trial focuses on Chronic Pain and remains actively recruiting participants. Sponsored by Saluda Medical Pty Ltd, it has been updated 15 times since 2020, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

~Jan 2021 – ~Feb 2021 · 31 days · monthly snapshot~Feb 2021 – ~Apr 2021 · 59 days · monthly snapshot~Apr 2021 – ~Jun 2021 · 2 months · monthly snapshot~Jun 2021 – ~Sep 2021 · 3 months · monthly snapshot~Sep 2021 – ~Dec 2021 · 3 months · monthly snapshot~Dec 2021 – ~Jul 2022 · 7 months · monthly snapshot~Jul 2022 – ~Sep 2022 · 2 months · monthly snapshot~Sep 2022 – ~Dec 2022 · 3 months · monthly snapshot~Dec 2022 – ~Dec 2023 · 12 months · monthly snapshot~Dec 2023 – ~Jan 2024 · 31 days · monthly snapshot~Jan 2024 – ~Jul 2024 · 6 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Jun 2025 · 9 months · monthly snapshot~Jun 2025 – ~Sep 2025 · 3 months · monthly snapshot~Sep 2025 – present · 11 months · monthly snapshot

Change History

15 versions recorded

  1. Sep 2025 — Present [monthly]

    Recruiting NA

  2. Jun 2025 — Sep 2025 [monthly]

    Recruiting NA

  3. Sep 2024 — Jun 2025 [monthly]

    Recruiting NA

  4. Jul 2024 — Sep 2024 [monthly]

    Recruiting NA

  5. Jan 2024 — Jul 2024 [monthly]

    Recruiting NA

▶ Show 10 earlier versions

  1. Dec 2023 — Jan 2024 [monthly]

    Recruiting NA

  2. Dec 2022 — Dec 2023 [monthly]

    Recruiting NA

  3. Sep 2022 — Dec 2022 [monthly]

    Recruiting NA

  4. Jul 2022 — Sep 2022 [monthly]

    Recruiting NA

  5. Dec 2021 — Jul 2022 [monthly]

    Recruiting NA

  6. Sep 2021 — Dec 2021 [monthly]

    Recruiting NA

  7. Jun 2021 — Sep 2021 [monthly]

    Recruiting NA

  8. Apr 2021 — Jun 2021 [monthly]

    Recruiting NA

  9. Feb 2021 — Apr 2021 [monthly]

    Recruiting NA

    Status: Not Yet Recruiting → Recruiting

  10. Jan 2021 — Feb 2021 [monthly]

    Not Yet Recruiting NA

    First recorded

Dec 2020

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Saluda Medical Pty Ltd
Data source: Saluda Medical Pty Ltd

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Auchenflower, Australia , Bella Vista, Australia , Brisbane, Australia , Broadmeadow, Australia , Charlestown, Australia , Clayton, Australia , Cottesloe, Australia , Fortitude Valley, Australia , Frankston, Australia , Garran, Australia and 11 more locations